ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. In a newly released interview, retired corporate ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The CEO estimated that about 55,000 new cases of metastatic pancreatic cancer are diagnosed annually in the U.S. RBC Capital raised RVMD’s target to $251 from $203 and maintained an ‘Outperform’ ...

Mark Goldsmith, Revolution Medicines CEO, joins 'Squawk on the Street' to discuss the FDA's approval of its breakthrough pancreatic cancer drug. Got a confidential news tip? We want to hear from you.

In a newly released interview, retired corporate executive Mark Goldsmith shares the extraordinary journey that led him from boardrooms to community rebuilding, founding GOSO, an agency that has ...